189 related articles for article (PubMed ID: 9863659)
21. Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea-pig ileum.
Lawrence RA; Jones RL; Wilson NH
Br J Pharmacol; 1992 Feb; 105(2):271-8. PubMed ID: 1559125
[TBL] [Abstract][Full Text] [Related]
22. Epoxyeicosatrienoic acids function as selective, endogenous antagonists of native thromboxane receptors: identification of a novel mechanism of vasodilation.
Behm DJ; Ogbonna A; Wu C; Burns-Kurtis CL; Douglas SA
J Pharmacol Exp Ther; 2009 Jan; 328(1):231-9. PubMed ID: 18836067
[TBL] [Abstract][Full Text] [Related]
23. The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats.
Tang EH; Jensen BL; Skott O; Leung GP; Feletou M; Man RY; Vanhoutte PM
Cardiovasc Res; 2008 Apr; 78(1):130-8. PubMed ID: 18093985
[TBL] [Abstract][Full Text] [Related]
24. EP3, but not EP2, FP, or TP prostanoid-receptor stimulation may reduce intraocular pressure.
Waterbury LD; Eglen RM; Faurot GF; Cooper GF
Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2560-7. PubMed ID: 2176184
[TBL] [Abstract][Full Text] [Related]
25. Prostanoid-induced relaxation of precontracted cat ciliary muscle is mediated by EP2 and DP receptors.
Chen J; Woodward DF
Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3195-201. PubMed ID: 1328113
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the prostaglandin E2 sensitive (EP)-receptor in the rat isolated trachea.
Lydford SJ; McKechnie K
Br J Pharmacol; 1994 May; 112(1):133-6. PubMed ID: 8032634
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the prostanoid receptors mediating constriction and relaxation of human isolated uterine artery.
Baxter GS; Clayton JK; Coleman RA; Marshall K; Sangha R; Senior J
Br J Pharmacol; 1995 Sep; 116(1):1692-6. PubMed ID: 8564239
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin E receptor subtypes involved in stimulation of gastroduodenal bicarbonate secretion in rats and mice.
Takeuchi K; Ukawa H; Furukawa O; Kawauchi S; Araki H; Sugimoto Y; Ishikawa A; Ushikubi F; Narumiya S
J Physiol Pharmacol; 1999 Jun; 50(2):155-67. PubMed ID: 10424714
[TBL] [Abstract][Full Text] [Related]
29. SC-46275: a potent and highly selective agonist at the EP3 receptor.
Savage MA; Moummi C; Karabatsos PJ; Lanthorn TH
Prostaglandins Leukot Essent Fatty Acids; 1993 Dec; 49(6):939-43. PubMed ID: 8140121
[TBL] [Abstract][Full Text] [Related]
30. Vasoconstriction induced by activation of EP1 and EP3 receptors in human lung: effects of ONO-AE-248, ONO-DI-004, ONO-8711 or ONO-8713.
Norel X; de Montpreville V; Brink C
Prostaglandins Other Lipid Mediat; 2004 Oct; 74(1-4):101-12. PubMed ID: 15560119
[TBL] [Abstract][Full Text] [Related]
31. The EP3-agonist sulprostone, but not prostaglandin E2 potentiates platelet aggregation in human blood.
Schober LJ; Khandoga AL; Penz SM; Siess W
Thromb Haemost; 2010 Jun; 103(6):1268-9. PubMed ID: 20431854
[No Abstract] [Full Text] [Related]
32. The role of prostanoid receptors in mediating the effects of PGE(2) on human platelet function.
Iyú D; Glenn JR; White AE; Johnson AJ; Fox SC; Heptinstall S
Platelets; 2010; 21(5):329-42. PubMed ID: 20433310
[TBL] [Abstract][Full Text] [Related]
33. Functional prostaglandin E (EP) receptors in human penile corpus cavernosum.
Moreland RB; Kim N; Nehra A; Goldstein I; Traish A
Int J Impot Res; 2003 Oct; 15(5):362-8. PubMed ID: 14562138
[TBL] [Abstract][Full Text] [Related]
34. Differential peristaltic motor effects of prostanoid (DP, EP, IP, TP) and leukotriene receptor agonists in the guinea-pig isolated small intestine.
Shahbazian A; Heinemann A; Peskar BA; Holzer P
Br J Pharmacol; 2002 Dec; 137(7):1047-54. PubMed ID: 12429577
[TBL] [Abstract][Full Text] [Related]
35. Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice.
Minami T; Nakano H; Kobayashi T; Sugimoto Y; Ushikubi F; Ichikawa A; Narumiya S; Ito S
Br J Pharmacol; 2001 Jun; 133(3):438-44. PubMed ID: 11375261
[TBL] [Abstract][Full Text] [Related]
36. Involvement of TP and EP3 receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature.
Janssen LJ; Tazzeo T
J Pharmacol Exp Ther; 2002 Jun; 301(3):1060-6. PubMed ID: 12023538
[TBL] [Abstract][Full Text] [Related]
37. EP4-receptors and cyclic AMP in pig venous smooth muscle: evidence with agonists and the EP4-antagonist, AH22921.
Coleman RA; Mallett A; Sheldrick RL
Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():241-6. PubMed ID: 7732844
[No Abstract] [Full Text] [Related]
38. Excitatory action of prostanoids on the ferret isolated vagus nerve preparation.
Kan KK; Jones RL; Ngan MP; Rudd JA
Eur J Pharmacol; 2004 Apr; 491(1):37-41. PubMed ID: 15102531
[TBL] [Abstract][Full Text] [Related]
39. Pharmacologic characteristics of non-prostanoid, non-nitric oxide mediated and endothelium-dependent relaxation of guinea-pig aorta in response to substance P.
Tanaka Y; Kaneko H; Tanaka H; Shigenobu K
Res Commun Mol Pathol Pharmacol; 1999 Jan; 103(1):65-81. PubMed ID: 10440572
[TBL] [Abstract][Full Text] [Related]
40. Idazoxan effects upon contractile activity in the rat aorta are related to alpha adrenoceptors and L-type channels.
Serban DN; Serban IL; Nechifor M
Fundam Clin Pharmacol; 2004 Dec; 18(6):635-41. PubMed ID: 15548234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
